On 5 November, Arovella CEO, Dr Nicole van der Weerden, spoke at the Bridge Life Sciences Executive Series: Targeting Cancer, co-hosted with IR Department. The webinar brings together investors and biotech leaders to discuss the science, commercial opportunities, and milestones shaping oncology.
This episode featured Presentations from:
Dr. Peter Meintjes (Pacific Edge): Non-invasive genomic diagnostic tests for bladder cancer.
Dr. Nicole van der Weerden (Arovella Therapeutics): Off-the-shelf cell therapies for blood and solid tumours.
Dr. Pete Smith (Racura Oncology): Novel cancer treatments and lead drug development.
View webinar (NB: recording begins at Arovella’s presentation)